ATNM vs TYL · rev $35.0M vs P/E 89, rev $1.26B
Actinium Pharmaceuticals Inc (ATNM) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
ATNM currently screens at market cap $33.9M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the ATNM and TYL stock pages for the full models.
Not investment advice.